A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines

被引:0
作者
Algar, EM
Khromykh, T
Smith, SI
Blackburn, DM
Bryson, GJ
Smith, PJ
机构
[1] UNIV QUEENSLAND,ROYAL BRISBANE HOSP,DEPT PATHOL,HERSTON,QLD 4006,AUSTRALIA
[2] ROYAL CHILDRENS HOSP,DEPT HAEMATOL & ONCOL,PARKVILLE,VIC 3052,AUSTRALIA
关键词
WT1; leukaemia; apoptosis;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The response of the CML-BC cell line, K562, the myelomonocytic cell line MM6 and the promyelocytic leukaemia cell line HL-60, to a 15 mer WT1 antisense oligonucleotide, targeted to the translation initiation site of the WT1 mRNA was examined. K562 cells exposed to 0.4 mu M antisense oligonucleotide showed markedly reduced proliferation which was associated with reduced cell viability. Sense, scrambled and mutant antisense oligonucleotides had no effect on the proliferation of K562 cells. MM6 cells exposed to 0.4 mu M antisense oligonucleotide also showed significantly reduced cellular proliferation which was also accompanied by loss of cell viability. In the K562 and MM6 antisense cultures that exhibited reduced cell viability, both DNA fragmentation and morphological features consistent with apoptosis could be identified. In contrast the growth of HL-60 cells was unaffected by exposure to oligonucleotide. In each of the cell WT1 antisense oligonucleotide abrogated WT1 protein expression, and analysis of WT1 coding sequence in these cells showed that no oncogenic point mutations in the gene were present. We propose therefore that in some myeloid leukaemia cell lines, the expression of a normal WT1 protein is necessary for cell proliferation and that it plays a role in maintaining the viability of some leukaemia cells.
引用
收藏
页码:1005 / 1014
页数:10
相关论文
共 27 条
[1]  
BAIRD PN, 1992, ONCOGENE, V7, P2141
[2]   APOPTOSIS AND EXPRESSION OF THE BCL-2 PROTOONCOGENE IN THE FETAL AND ADULT HUMAN KIDNEY - EVIDENCE FOR THE CONTRIBUTION OF BCL-2 EXPRESSION TO RENAL CARCINOGENESIS [J].
CHANDLER, D ;
ELNAGGAR, AK ;
BRISBAY, S ;
REDLINE, RW ;
MCDONNELL, TJ .
HUMAN PATHOLOGY, 1994, 25 (08) :789-796
[3]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[4]   WT1 SUPPRESSES SYNTHESIS OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND INDUCES APOPTOSIS [J].
ENGLERT, C ;
HOU, X ;
MAHESWARAN, S ;
BENNETT, P ;
NGWU, C ;
RE, GG ;
GARVIN, AJ ;
ROSNER, MR ;
HABER, DA .
EMBO JOURNAL, 1995, 14 (19) :4662-4675
[5]   HOMOZYGOUS DELETION IN WILMS-TUMORS OF A ZINC-FINGER GENE IDENTIFIED BY CHROMOSOME JUMPING [J].
GESSLER, M ;
POUSTKA, A ;
CAVENEE, W ;
NEVE, RL ;
ORKIN, SH ;
BRUNS, GAP .
NATURE, 1990, 343 (6260) :774-778
[6]   INHIBITION OF APOPTOSIS BY THE RETINOBLASTOMA GENE-PRODUCT [J].
HAASKOGAN, DA ;
KOGAN, SC ;
LEVI, D ;
DAZIN, P ;
TANG, A ;
FUNG, YKT ;
ISRAEL, MA .
EMBO JOURNAL, 1995, 14 (03) :461-472
[7]  
HABER DA, 1992, CANCER SURV, V12, P105
[8]   ALTERNATIVE SPLICING AND GENOMIC STRUCTURE OF THE WILMS-TUMOR GENE-WT1 [J].
HABER, DA ;
SOHN, RL ;
BUCKLER, AJ ;
PELLETIER, J ;
CALL, KM ;
HOUSMAN, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) :9618-9622
[9]   WT1 AS A NEW PROGNOSTIC FACTOR AND A NEW MARKER FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA [J].
INOUE, K ;
SUGIYAMA, H ;
OGAWA, H ;
NAKAGAWA, M ;
YAMAGAMI, T ;
MIWA, H ;
KITA, K ;
HIRAOKA, A ;
MASAOKA, T ;
NASU, K ;
KYO, T ;
DOHY, H ;
NAKAUCHI, H ;
ISHIDATE, T ;
AKIYAMA, T ;
KISHIMOTO, T .
BLOOD, 1994, 84 (09) :3071-3079
[10]   WT-1 IS REQUIRED FOR EARLY KIDNEY DEVELOPMENT [J].
KREIDBERG, JA ;
SARIOLA, H ;
LORING, JM ;
MAEDA, M ;
PELLETIER, J ;
HOUSMAN, D ;
JAENISCH, R .
CELL, 1993, 74 (04) :679-691